Literature DB >> 11045557

Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats.

J S Jahng1, H W Kim.   

Abstract

The effects of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats were examined to evaluate its potential use as a therapeutic agent for osteoporotic fractures. Three months postovariectomy, bilateral tibial shaft fractures were induced and stabilized by intramedullary nailing with Kirschner wires. Saline, 17beta-estradiol (Sigma Chemical Corp, St Louis, Mo), or recombinant human parathyroid hormone (1-84) (Korean Green-Cross Pharm Corp, Seoul, Korea) was given once a day for 30 consecutive days during fracture healing. Fracture healing was assessed by morphometric and mechanical analysis of fracture callus. Intermittent parathyroid hormone administration increased the morphometric and mechanical parameters in a dose-dependent manner. A bone-resorption inhibiting agent, 17beta-estradiol did not offer advantage in terms of fracture healing in ovariectomized rats. Findings suggest intermittent parathyroid hormone administration may benefit osteoporosis and fracture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045557     DOI: 10.3928/0147-7447-20001001-22

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  15 in total

Review 1.  The potential of gene therapy for fracture healing in osteoporosis.

Authors:  M Egermann; E Schneider; C H Evans; A W Baltzer
Journal:  Osteoporos Int       Date:  2005-01-15       Impact factor: 4.507

2.  Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.

Authors:  Chandrika D Mahalingam; Tanuka Datta; Rashmi V Patil; Jaclynn Kreider; R Daniel Bonfil; Keith L Kirkwood; Steven A Goldstein; Abdul B Abou-Samra; Nabanita S Datta
Journal:  J Endocrinol       Date:  2011-08-18       Impact factor: 4.286

Review 3.  Effects of anti-osteoporosis medications on fracture healing.

Authors:  Niklas R Jørgensen; Peter Schwarz
Journal:  Curr Osteoporos Rep       Date:  2011-09       Impact factor: 5.096

4.  PTH 1-84: bone rebuilding as a target for the therapy of severe osteoporosis.

Authors:  Fabio Vescini; Franco Grimaldi
Journal:  Clin Cases Miner Bone Metab       Date:  2012-05-29

5.  Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model.

Authors:  David G Reynolds; Masahiko Takahata; Amy L Lerner; Regis J O'Keefe; Edward M Schwarz; Hani A Awad
Journal:  Bone       Date:  2010-10-13       Impact factor: 4.398

6.  Tensile type of stress fracture neck of femur: role of teriparatide in the process of healing in a high risk patient for impaired healing of fracture.

Authors:  Rajesh Malhotra; Sanjay Meena; Vijay Kumar Digge
Journal:  Clin Cases Miner Bone Metab       Date:  2013-09

7.  Recent advances toward the clinical application of PTH (1-34) in fracture healing.

Authors:  Cara A Cipriano; Paul S Issack; Lisa Shindle; Clément M L Werner; David L Helfet; Joseph M Lane
Journal:  HSS J       Date:  2009-03-17

8.  Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats.

Authors:  Y F Li; E Luo; G Feng; S S Zhu; J H Li; J Hu
Journal:  Osteoporos Int       Date:  2009-12-03       Impact factor: 4.507

9.  Role of parathyroid hormone in the mechanosensitivity of fracture healing.

Authors:  Michael J Gardner; Marjolein C H van der Meulen; Joshua Carson; Jonathan Zelken; Benjamin F Ricciardi; Timothy M Wright; Joseph M Lane; Mathias P Bostrom
Journal:  J Orthop Res       Date:  2007-11       Impact factor: 3.494

Review 10.  The aging spine: new technologies and therapeutics for the osteoporotic spine.

Authors:  Joseph M Lane; Michael J Gardner; Julie T Lin; Marjolein C van der Meulen; Elizabeth Myers
Journal:  Eur Spine J       Date:  2003-10-08       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.